Page 3 - Best Lymphoma doctors: TOP 91 doctors

Chief Physician at BKZ Solingen's cancer center – Dr. Fox leads Germany's top team for lymphoma treatment with innovative therapies.

• Specialist in haematology, oncology, and immunology since 2011
• Pioneers molecular diagnostics and targeted therapies
• Active researcher in haemato-oncological disease treatments
• Member of American Association for Cancer Research
• Qualified genetics specialist since 2016

Prof. Dr. Hasan Atilla Ozkan leads the Turkish Therapeutic Apheresis Association and specializes in lymphoma treatment at VM Medical Park Pendik Hospital.

• Over 23 years of experience of experience in hematology and internal medicine
• Certified in autologous and allogeneic stem cell transplantation
• Member of EBMT (European Society for Blood and Marrow Transplantation)
• Recipient of the 2011 Young Researcher Award in Therapeutic Apheresis

Professor Drach led the Multiple Myeloma and Malignant Lymphoma program at one of Europe's largest public hospitals – Vienna's General Hospital (AKH).

• Over of specialist experience in internal medicine and oncology
• Completed a research fellowship at the M.D. Anderson Cancer Center in the USA
• Published more than 120 scientific papers on hematologic cancers
• Current Director of the Josefstadt Private Clinic in Vienna
• Board member of the Austrian Society of Hematology and Oncology

Dr. Eckhart Weidmann specializes in non-Hodgkin lymphoma with 900+ procedures performed as head of hematology at Nordwest Clinic.

• 36 years of experience of experience in oncology and oncohematology
• Professor and chief of the Hematology Department
• Performed over 1,100 procedures in his career
• Expert in blood disorder treatments

Recognized as one of Israel's best doctors by Forbes in 2019-2020, Dr. Gal Goldstein is the Head of Pediatric Oncology at Hadassah Hospital.

• Specializes exclusively in pediatric hemato-oncology for over 27 years of experience
• Expert in advanced treatments like haploidentical bone marrow transplants
• Deep focus on specific childhood cancers, including retinoblastoma
• Active member of international oncology societies like SIOP
• Employs precision medicine to personalize treatment plans

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL) and lymphoma research, with over 80 ongoing clinical trials.

• Specializes in lymphomas and chronic lymphocytic leukemia with innovative treatment approaches
• President of the Spanish group for CLL study (GELLC)
• Head of Hematology at IOB Institute of Oncology and Vall d'Hebron University Hospital
• Published over 100 articles in top medical journals including NEJM and Nature Medicine

Specializes exclusively in lymphoma, focusing his practice on this complex blood cancer at Rambam Medical Center.

• A hematologist with deep expertise in lymphoma subtypes
• Provides targeted treatments for this specific condition
• Based at a leading tertiary care and research hospital

Karen Drumea is a specialist in radiotherapy for oncology, focusing on treating cancer patients with radiation at Rambam Medical Center.

• Years of experience in radiation oncology and general oncology
• Specializes in using radiotherapy to treat cancers
• Based at Rambam Medical Center in Israel
• Combines expertise in both radiation and medical oncology for patient care

Professor Zuckerman specializes exclusively in hematology and stem cell transplant for lymphoma at Rambam Medical Center.

• Over of experience in hematology and transplant medicine
• Focuses on bone marrow and stem cell transplantation for lymphoma patients
• Serves as a senior physician and professor at Rambam Medical Center
• Expertise in complex cases requiring advanced transplant protocols